Literature DB >> 28918108

Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.

Kay-Won Chang1, Neil Beri1, Nghia H Nguyen1, Boris Arbit1, Sutton Fox1, Sean Mojaver1, Paul Clopton1, S William Tam2, Anne L Taylor3, Jay N Cohn4, Alan S Maisel1, Inder S Anand5.   

Abstract

BACKGROUND: Recent studies have described the entity of heart failure with recovered ejection fraction (HFrecEF), but population-specific studies remain lacking. The aim of this study was to characterize patients enrolled in the African-American Heart Failure Trial (A-HeFT) who had significant improvement in their ejection fraction (EF) during the 1st 6 months of follow-up. METHODS AND
RESULTS: Subjects with HFrecEF (improvement in EF from <35% to >40% in 6 months; n = 59) were compared with 259 subjects with heart failure and persistently reduced EF (HFrEF), defined as EF ≤40% at 6-month follow-up. The effects of improvement in EF on all-cause mortality and 1st and all hospitalizations were analyzed. Compared with HFrEF, subjects with HFrecEF had a nonsignificant trend toward lower mortality (hazard ratio [HR] 0.16, 95% confidence interval [CI] 0.02-1.15; P = .068), fewer 1st HF hospitalizations (HR 0.22, 95% CI 0.07-0.71; P = .011), fewer recurrent HF hospitalizations (HR 0.13, 95% CI 0.05-0.37; P <.001), similar 1st all-cause hospitalizations (HR 0.67, 95% CI 0.39-1.15; P = .150), and fewer recurrent all-cause hospitalizations (HR 0.41, 95% CI 0.24-0.68; P <.001).
CONCLUSIONS: These data confirm that, as in other populations, a small subgroup of black patients receiving standard care improve their EF with favorable outcomes. Further studies are required to determine whether myocardial recovery is permanent and the best management strategies in such patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African American; Heart failure; black; hydralazine; isosorbide dinitrate; recovered ejection fraction

Mesh:

Substances:

Year:  2017        PMID: 28918108     DOI: 10.1016/j.cardfail.2017.09.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  6 in total

Review 1.  Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction.

Authors:  Jakrin Kewcharoen; Angkawipa Trongtorsak; Sittinun Thangjui; Chanavuth Kanitsoraphan; Narut Prasitlumkum
Journal:  Med Sci (Basel)       Date:  2022-04-02

2.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

3.  Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy.

Authors:  Walter B Schiffer; Andrew Perry; Elena Deych; David L Brown; Luigi Adamo
Journal:  Open Heart       Date:  2021-03

4.  Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure.

Authors:  Li-Fang Ye; Xue-Ling Li; Shao-Mei Wang; Yun-Fan Wang; Ya-Ru Zheng; Li-Hong Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-01

5.  A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease.

Authors:  Haozhang Huang; Jin Liu; Min Lei; Zhou Yang; Kunming Bao; Qiang Li; Wenguang Lai; Bo Wang; Yibo He; Shiqun Chen; Chun-Quan Ou; Maimaitiaili Abudukerimu; Yuying Hu; Ning Tan; Jiyan Chen; Yong Liu
Journal:  Front Physiol       Date:  2021-12-03       Impact factor: 4.566

6.  Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis.

Authors:  Yibo He; Yihang Ling; Wei Guo; Qiang Li; Sijia Yu; Haozhang Huang; Rongting Zhang; Zhiwen Gong; Jiaxuan Liu; Liyi Mo; Shixin Yi; Disheng Lai; Younan Yao; Jin Liu; Jiyan Chen; Yong Liu; Shiqun Chen
Journal:  Front Cardiovasc Med       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.